PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.231
https://www.valueinhealthjournal.com/article/S1098-3015(18)33531-9/fulltext
Title :
PCN148 - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33531-9&doi=10.1016/j.jval.2018.09.231
First page :
Section Title :
Open access? :
No
Section Order :
1668